Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus Acidophilus L-92 for Allergic Rhinitis
NCT00554736Phase 3Withdrawn
- Sponsor
- University of California, Davis
- Start
- May 2006
- Primary completion
- Dec 2007
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 3 trial of Lactobacillus acidophilus L-92 in allergic rhinitis (AR), sponsored by University of California, Davis. Planned start May 2006; status: withdrawn.
02
Drugs
Lactobacillus acidophilus L-92
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00554736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00554736.